New York State Common Retirement Fund Provention Bio, Inc. Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$6.7 - $24.21 $301 - $1,089	45 Added 0.13%	34,954 $842,000
Q4 2022 Jan 30, 2023	BUY	$4.52 - $10.57 $34,808 - $81,399	7,701 Added 28.3%	34,909 $369,000
Q3 2022 Nov 08, 2022	BUY	$3.43 - $5.62 $346 - $567	101 Added 0.37%	27,208 $122,000
Q2 2022 Aug 04, 2022	SELL	$3.65 - $7.3 $284 - $569	-78 Reduced 0.29%	27,107 $108,000
Q1 2022 May 05, 2022	BUY	$3.4 - $7.88 $119 - $275	35 Added 0.13%	27,185 $199,000
Q4 2021 Feb 02, 2022	SELL	$5.59 - $7.39 $788 - $1,041	-141 Reduced 0.52%	27,150 $153,000
Q3 2021 Nov 02, 2021	SELL	$5.66 - $8.33 $83,530 - $122,934	-14,758 Reduced 35.1%	27,291 $175,000
Q2 2021 Aug 02, 2021	BUY	$6.71 - $11.04 $3,012 - $4,956	449 Added 1.08%	42,049 $354,000
Q1 2021 May 11, 2021	BUY	$10.12 - $19.45 $28,335 - $54,460	2,800 Added 7.22%	41,600 $437,000
Q2 2020 Aug 07, 2020	BUY	$7.81 - $17.0 $303,028 - $659,600	38,800 New	38,800 $547,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.